Literature DB >> 17242951

The seroepidemiology of tetanus in Catalonia, Spain.

A Domínguez1, P Plans, J Costa, J Espuñes, N Cardeñosa, L Salleras, A Plasència.   

Abstract

Titres of anti-tetanus toxin antibodies > or = 0.1 IU/ml were determined using an enzyme linked immunosorbent assay in representative samples of the juvenile and adult population of Catalonia. The prevalence obtained in 1,316 juveniles and 1,296 adults was 99.4 and 68.3%, respectively. In adults, the prevalence in males (76.5%) was higher (P < 0.001) than in females (61.7%), fell with increasing age and was higher in subjects born in Catalonia (72.5%) than in those born outside Catalonia (57.9%) (P < 0.001). These results show that routine vaccination of children is successful. In adults aged > or = 45 years, the prevalence is inadequate and efforts should be made to increase vaccination.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17242951     DOI: 10.1007/s00430-007-0035-4

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  29 in total

1.  Immunogenicity and reactogenicity of the adult tetanus-diphtheria vaccine. How many doses are necessary?

Authors:  J M Bayas; A Vilella; M J Bertran; J Vidal; J Batalla; M A Asenjo; L L Salleras
Journal:  Epidemiol Infect       Date:  2001-12       Impact factor: 2.451

2.  Recommended childhood and adolescent immunization schedule--United States, January-June 2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-01-16       Impact factor: 17.586

3.  Evaluation of the national immunisation programme in the Netherlands: immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella and Haemophilus influenzae type b.

Authors:  H E de Melker; S van den Hof; G A M Berbers; M A E Conyn-van Spaendonck
Journal:  Vaccine       Date:  2003-01-30       Impact factor: 3.641

4.  Age-specific seroprevalence of poliomyelitis, diphtheria and tetanus antibodies in Spain.

Authors:  I Pachón; C Amela; F De Ory
Journal:  Epidemiol Infect       Date:  2002-12       Impact factor: 2.451

5.  Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus.

Authors:  Michael S Deming; Jean-Baptiste Roungou; Max Kristiansen; Iver Heron; Alphonse Yango; Alexis Guenengafo; Robert Ndamobissi
Journal:  Bull World Health Organ       Date:  2002       Impact factor: 9.408

6.  Immunity to diphtheria and tetanus in Australia: a national serosurvey.

Authors:  Heather F Gidding; Josephine L Backhouse; Margaret A Burgess; Gwendolyn L Gilbert
Journal:  Med J Aust       Date:  2005-09-19       Impact factor: 7.738

7.  Tetanus seroprevalence among farmers: a preliminary study.

Authors:  Mary S Hayney; Gayle Dienberg Love; Beth M Carlberg; Jessica M Buck; Daniel Muller
Journal:  J Rural Health       Date:  2003       Impact factor: 4.333

8.  Tetanus immunisation in geriatric patients with accidental wounds: how much is needed?

Authors:  Hans Dieter Hüllstrung; Daniel Mäusezahl; Mirjam Feuz; Christian Herzog; Martin Conzelmann; Werner Zimmerli
Journal:  Swiss Med Wkly       Date:  2003-04-19       Impact factor: 2.193

9.  Seroprevalence of tetanus immunity among noninsulin-dependent diabetes mellitus patients.

Authors:  Dilek Kiliç; Sedat Kaygusuz; Meral Saygun; Aytül Cakmak; Hazel Uzer; Levent Doğanci
Journal:  J Diabetes Complications       Date:  2003 Sep-Oct       Impact factor: 2.852

10.  Tetanus surveillance--United States, 1995-1997.

Authors:  B Bardenheier; D R Prevots; N Khetsuriani; M Wharton
Journal:  MMWR CDC Surveill Summ       Date:  1998-07-03
View more
  1 in total

1.  Determination of Tetanus Antibody Levels in Trauma Patients Referred To Shahid Beheshti Hospital in Kashan, Iran, 2014.

Authors:  Hasan Afzali; Mohammad Reza Sharif; Shamsaddin Mousavi
Journal:  Arch Trauma Res       Date:  2015-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.